Cost-Effectiveness of Newer Antidiabetic Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review

被引：0
|
作者：
Jiejin Zhu
Ying Zhou
Qingyu Li
Gang Wang
机构：
[1] Zhejiang University School of Medicine,Department of Clinical Pharmacy, Affiliated Hangzhou First People’s Hospital
[2] Zhejiang University School of Medicine,Department of Pharmacy, Affiliated Hangzhou Cancer Hospital
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Cost-effectiveness; Dipeptidyl peptidase 4 inhibitor; Glucagon-like peptide 1 receptor agonist; Second-line treatment; Sodium-glucose transporter 2 inhibitor; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4216 / 4235
页数：19
相关论文
共 50 条
  • [21] Type 2 diabetes: second-line antidiabetic therapy in early pregnancy
    Clauss, Maria
    [J]. ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2024, 228 (02): : 119 - 119
  • [22] Cost-effectiveness analysis of second-line pharmacological treatment of acromegaly in Spain
    Peral, Carmen
    Cordido, Fernando
    Gimeno-Ballester, Vicente
    Mir, Nuria
    Sanchez-Cenizo, Laura
    Rubio-Rodriguez, Dario
    Rubio-Terres, Carlos
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2020, 20 (01) : 105 - 114
  • [23] Cost-Effectiveness of Cabozantinib in the Second-Line Treatment of Advanced Hepatocellular Carcinoma
    Soto-Perez-de-Celis, Enrique
    Aguiar, Pedro N., Jr.
    Cordon, Monica L.
    Chavarri-Guerra, Yanin
    Lopes, Gilberto de Lima, Jr.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (06): : 669 - 675
  • [24] Comparison of Glucose-Lowering Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Gu, Shuyan
    Hu, Xiaoqian
    Zhen, Xuemei
    Shi, Lizheng
    Shao, Hui
    Sun, Xueshan
    Gu, Yuxuan
    Huang, Minzhuo
    Dong, Hengjin
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (18)
  • [25] Outcomes of second-line oral antidiabetic drugs in persons with young-onset type 2 diabetes
    Yen, Fu-Shun
    Wei, James Cheng-Chung
    Liu, Jia-Sin
    Hsu, Chih-Cheng
    Hwu, Chii-Min
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 177
  • [26] Cost-Effectiveness of Saxagliptin Compared With Glibenclamide as a Second-Line Therapy Added to Metformin for Type 2 Diabetes Mellitus in Ethiopia
    Bekele, Mengistu
    Norheim, Ole Frithjof
    Hailu, Alemayehu
    [J]. MDM POLICY & PRACTICE, 2021, 6 (01)
  • [27] PATIENTS' PREFERENCES FOR NEWER SECOND-LINE PHARMACOLOGICAL AGENTS IN TYPE 2 DIABETES
    Banjara, B.
    Poudel, N.
    Garza, K. B.
    Westrick, S. C.
    Whitley, H. P.
    Ngorsuraches, S.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S566 - S566
  • [28] Cost-effectiveness of treatment of type 2 diabetes
    Eastman, RC
    [J]. DIABETES CARE, 1998, 21 (03) : 464 - 465
  • [29] Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus
    Sanchez Fernandez, Ivann
    Gainza-Lein, Marina
    Lamb, Nathan
    Loddenkemper, Tobias
    [J]. NEUROLOGY, 2019, 92 (20) : E2339 - E2348
  • [30] COST-EFFECTIVENESS ANALYSIS OF PHARMACOLOGICAL TREATMENT PATHWAYS FOR TYPE 2 DIABETES DRUGS
    Kwon, C. S.
    Seoane-Vazquez, E.
    Rodriguez-Monguio, R.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A202 - A202
12345